Fig. 2From: A novel genomic signature predicting FDG uptake in diverse metastatic tumorsRMSE values in the validation set (with or without influential observation) of PLS-3 signatures with different number of probes ((+) only probes with positive regression coefficients, (mix) probes with both positive and negative regression coefficients, and(−) only probes with negative regression coefficients)Back to article page